Putting Science to Work

Archives / 2019 / October

  • Syngene International Q2 profit up 64 pc to Rs 128 cr.

    Business Standard- 22/10/2019. Continued growth in our Discovery Services business, combined with consistent performances in our dedicated R and D centres and Development Services business were key to this performance.


Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget